Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”

por van Kempen, Zoé LE, Rispens, Theo, Killestein, Joep
Publicado 2017

Keep your eyes on the prize: Tackling breakthrough COVID-19 in MS patients

por van Kempen, Zoé LE, Killestein, Joep, Hartung, Hans-Peter
Publicado 2021

COVID-19 in multiple sclerosis: The Dutch experience

por Loonstra, Floor C, Hoitsma, Elske, van Kempen, Zoé LE, Killestein, Joep, Mostert, Jop P
Publicado 2020

Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab

por van Kempen, Zoé L.E., Kummer, Laura Y.L., Wieske, Luuk, Rispens, Theo, Eftimov, Filip, Killestein, Joep
Publicado 2022

Infusion-related events during natalizumab: No need for post-infusion monitoring

por Loonstra, Floor C, van Rossum, Johannis A, van Kempen, Zoé LE, Rispens, Theo, Uitdehaag, Bernard MJ, Killestein, Joep
Publicado 2019

Fingerprick blood samples to measure serum natalizumab concentrations

por Toorop, Alyssa A, Steenhuis, Maurice, Loeff, Floris C, Weijers, Suzanne S, Killestein, Joep, Rispens, Theo, van Kempen, Zoé LE
Publicado 2022

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing

por van Kempen, Zoé LE, Leurs, Cyra E, Witte, Birgit I, de Vries, Annick, Wattjes, Mike P, Rispens, Theo, Killestein, Joep
Publicado 2017

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients

por Leurs, Cyra E, van Kempen, Zoé LE, Dekker, Iris, Balk, Lisanne J, Wattjes, Mike P, Rispens, Theo, Uitdehaag, Bernard MJ, Killestein, Joep
Publicado 2017

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis

por Toorop, Alyssa A, Rispens, Theo, Strijbis, Eva MM, van Oosten, Bob W, de Jong, Brigit A, Uitdehaag, Bernard MJ, Killestein, Joep, van Kempen, Zoé LE
Publicado 2021

Intracerebral lymphoproliferative disorder in an MS patient treated with fingolimod

por de Jong, Brigit A., van Kempen, Zoé L.E., Wattjes, Mike P., Smit, Patrick M., Peferoen, Laura, Berry, Daniella, Chamuleau, Martine E.D., de Jong, Daphne
Publicado 2018

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

por Toorop, Alyssa A., van Lierop, Zoë Y.G., Strijbis, Eva E.M., Teunissen, Charlotte E., Petzold, Axel, Wattjes, Mike P., Barkhof, Frederik, de Jong, Brigit A., van Kempen, Zoé L.E., Killestein, Joep
Publicado 2020

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light

por Wessels, Mark HJ, Van Lierop, Zoë YGJ, Noteboom, Samantha, Strijbis, Eva MM, Heijst, Johannes A, Van Kempen, Zoé LE, Moraal, Bastiaan, Barkhof, Frederik, Uitdehaag, Bernard MJ, Schoonheim, Menno M, Killestein, Joep, Teunissen, Charlotte E
Publicado 2023

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis

por van Lierop, Zoë YGJ, Noteboom, Samantha, Steenwijk, Martijn D, van Dam, Maureen, Toorop, Alyssa A, van Kempen, Zoé LE, Moraal, Bastiaan, Barkhof, Frederik, Uitdehaag, Bernard MJ, Schoonheim, Menno M, Teunissen, Charlotte E, Killestein, Joep
Publicado 2022

Disease activity following pregnancy-related discontinuation of natalizumab in MS

por Kleerekooper, Iris, van Kempen, Zoé L.E., Leurs, Cyra E., Dekker, Iris, Rispens, Theo, Lissenberg-Witte, Birgit I., van Munster, Caspar E.P., de Jong, Brigit A., van Oosten, Bob W., Uitdehaag, Bernard M.J., Wattjes, Mike P., Killestein, Joep
Publicado 2017

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic

por van Lierop, Zoë YGJ, Toorop, Alyssa A, van Ballegoij, Wouter JC, Olde Dubbelink, Tom BG, Strijbis, Eva MM, de Jong, Brigit A, van Oosten, Bob W, Moraal, Bastiaan, Teunissen, Charlotte E, Uitdehaag, Bernard MJ, Killestein, Joep, van Kempen, Zoé LE
Publicado 2021

Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod

por Palomares Cabeza, Virginia, Kummer, Laura Y.L., Wieske, Luuk, Hagen, Ruth R., Duurland, Mariel, Konijn, Veronique A.L., van Dam, Koos P.J., Stalman, Eileen W., van de Sandt, Carolien E., Boekel, Laura, Verstegen, Niels J.M., Steenhuis, Maurice, Rispens, Theo, Tas, Sander W., Wolbink, Gertjan, Killestein, Joep, Kuijpers, Taco W., van Ham, S. Marieke, Eftimov, Filip, Brinke, Anja ten, van Kempen, Zoé L.E.
Publicado 2022

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

por Verstegen, Niels JM, Hagen, Ruth R, van den Dijssel, Jet, Kuijper, Lisan H, Kreher, Christine, Ashhurst, Thomas, Kummer, Laura YL, Steenhuis, Maurice, Duurland, Mariel, de Jongh, Rivka, de Jong, Nina, van der Schoot, C Ellen, Bos, Amélie V, Mul, Erik, Kedzierska, Katherine, van Dam, Koos PJ, Stalman, Eileen W, Boekel, Laura, Wolbink, Gertjan, Tas, Sander W, Killestein, Joep, van Kempen, Zoé LE, Wieske, Luuk, Kuijpers, Taco W, Eftimov, Filip, Rispens, Theo, van Ham, S Marieke, ten Brinke, Anja, van de Sandt, Carolien E
Publicado 2022

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

por van Dam, Koos P.J., Wieske, Luuk, Stalman, Eileen W., Kummer, Laura Y.L., Roosen, Jesse, van Kempen, Zoé L.E., Killestein, Joep, Volkers, Adriaan G., Boekel, Laura, Wolbink, Gerrit J., van der Kooi, Anneke J., Raaphorst, Joost, Löwenberg, Mark, Takkenberg, R. Bart, D'Haens, Geert R.A.M., Spuls, Phyllis I., Bekkenk, Marcel W., Musters, Annelie H., Post, Nicoline F., Bosma, Angela L., Hilhorst, Marc L., Vegting, Yosta, Bemelman, Frederike J., Voskuyl, Alexandre E., Broens, Bo, Sanchez, Agner Parra, van Els, Cécile A.C.M., de Wit, Jelle, Rutgers, Abraham, de Leeuw, Karina, Horváth, Barbara, Verschuuren, Jan J.G.M., Ruiter, Annabel M., van Ouwerkerk, Lotte, van der Woude, Diane, Allaart, Renée C.F., Teng, Y.K. Onno, van Paassen, Pieter, Busch, Matthias H., Jallah, Papay B.P., Brusse, Esther, van Doorn, Pieter A., Baars, Adája E., Hijnen, Dirk Jan, Schreurs, Corine R.G., van der Pol, W.Ludo, Goedee, H. Stephan, Steenhuis, Maurice, Keijzer, Sofie, Keijser, Jim B.D., Cristianawati, Olvi, Rispens, Theo, Brinke, Anja ten, Verstegen, Niels J.M., Marieke van Ham, S., Tas, Sander W., Kuijpers, Taco W., Eftimov, Filip
Publicado 2023